Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|February 9, 2010
Pfizer stakes a claim in plant cell-made biopharmaceuticalsMark Ratner
Nature Biotechnology|August 8, 2015
Microbial cocktails join fecal transplants in IBD treatment trialsMark Ratner
Nature Biotechnology|December 9, 2017
Amgen cholesterol antibody feud could kill key IP ruleMark Ratner
Nature Biotechnology|December 13, 2006
Profile: Daphne ZoharMark Ratner
Nature Biotechnology|April 8, 2006
Complement inhibitors finally find orphan nichesMark Ratner
Nature Biotechnology|August 8, 2014
Next-generation AMD drugs to wed blockbustersMark Ratner
Nature Biotechnology|October 10, 2009
Spotlight focuses on protein-misfolding therapiesMark Ratner
Nature Biotechnology|May 10, 2014
HIV treatment study clears virus, sends Sangamo stock soaringMark Ratner
Nature Biotechnology|May 13, 2015
Biogen's early Alzheimer's data raise hopes, some eyebrowsMark Ratner
Nature Biotechnology|August 9, 2012
Shire punts on bioscaffolds for cell-based regenerative medicineMark Ratner
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|February 9, 2010
Pfizer stakes a claim in plant cell-made biopharmaceuticalsMark Ratner
Nature Biotechnology|August 8, 2015
Microbial cocktails join fecal transplants in IBD treatment trialsMark Ratner
Nature Biotechnology|December 9, 2017
Amgen cholesterol antibody feud could kill key IP ruleMark Ratner
Nature Biotechnology|December 13, 2006
Profile: Daphne ZoharMark Ratner
Nature Biotechnology|April 8, 2006
Complement inhibitors finally find orphan nichesMark Ratner
Nature Biotechnology|August 8, 2014
Next-generation AMD drugs to wed blockbustersMark Ratner
Nature Biotechnology|October 10, 2009
Spotlight focuses on protein-misfolding therapiesMark Ratner
Nature Biotechnology|May 10, 2014
HIV treatment study clears virus, sends Sangamo stock soaringMark Ratner
Nature Biotechnology|May 13, 2015
Biogen's early Alzheimer's data raise hopes, some eyebrowsMark Ratner
Nature Biotechnology|August 9, 2012
Shire punts on bioscaffolds for cell-based regenerative medicineMark Ratner
Pageof 11